GlassScriptPhysician profile
Charles H Edwards
NPI 1821071523
$2,542.06
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $38.05 · 2020: $34.02 · 2021: $2,272 · 2022: $76.75 · 2023: $122.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $122.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $121.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eli Lilly and Company | $1,875.00 | 2021 | |
| Acadia Pharmaceuticals INC | $126.01 | 2020-2023 | Nuplazid |
| Sunovion Pharmaceuticals INC. | $117.96 | 2021 | |
| Acorda Therapeutics, INC | $78.30 | 2021-2022 | |
| Otsuka America Pharmaceutical, INC. | $60.88 | 2023 | Nuedexta, Rexulti |
| Merz Pharmaceuticals, LLC | $59.95 | 2021 | |
| Ge Healthcare | $53.53 | 2020-2021 | |
| Teva Pharmaceuticals USA, INC. | $38.05 | 2019 | |
| Avanir Pharmaceuticals, INC. | $31.40 | 2021 | |
| Corium, LLC | $24.86 | 2023 | Adlarity |
| Neurocrine Biosciences, INC. | $24.11 | 2021 | |
| Abbvie INC. | $21.36 | 2022 | |
| Lilly USA, LLC | $16.21 | 2023 | Amyvid |
| Lundbeck LLC | $14.44 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Edwards listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.